CPHA Canvax

"The purpose of this document is to update previous NACI recommendations for the use of PVZ, taking into consideration recent data on burden of illness due to RSV disease, the efficacy and effectiveness of PVZ in infants at risk of more severe RSV disease and economic implications of PVZ use." - Recommended use of palivizumab to reduce complications of respiratory syncytial virus infection in infants

Rating See Comments Ratings


Program Planning and Delivery,Program Delivery and Evaluation,Guides,Monitoring and Surveillance,Outbreaks and Pandemics,Outbreaks Program Planning and Delivery
Program Delivery and Evaluation
Monitoring and Surveillance
Outbreaks and Pandemics


Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.